Phase I study of decitabine in combination with vorinostat in patients with advanced solid tumors and non-Hodgkin's lymphomas

Por Stathis, Anastasios, Hotte, Sebastien J., Chen, Eric X., Hirte, Holger W., Oza, Amit M., Moretto, Patricia, Webster, Sheila, Laughlin, Anne, Stayner, Lee-Anne, McGill, Shauna, Wang, Lisa, Zhang, Wen-jiang, Espinoza-Delgado, Igor, Holleran, Julianne L., Egorin, Merrill J., Siu, Lillian L.
Publicado em 2009

A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia

Por How, Jonathan, Minden, Mark D., Brian, Leber, Chen, Eric X., Brandwein, Joseph, Schuh, Andre C., Schimmer, Aaron D., Gupta, Vikas, Webster, Sheila, Degelder, Tammy, Haines, Patricia, Stayner, Lee-Anne, McGill, Shauna, Wang, Lisa, Piekarz, Richard, Wong, Tracy, Siu, Lillian L., Espinoza-Delgado, Igor, Holleran, Julianne L., Egorin, Merrill J., Yee, Karen W. L.
Publicado no Leuk Lymphoma (2015)